Effectiveness of metyrapone in treating Cushing's Syndrome: a retrospective multicenter study in 195 patients.

Daniel, E; Aylwin, S; Mustafa, O; Ball, S; Munir, A; Boelaert, K; Chortis, V; Cuthbertson, D; Daousi, C; Rajeev, S; Davis, J; Cheer, K; Drake, W; Gunganah, K; Grossman, A; Gurnell, M; Powlson, A; Karavitaki, N; Huguet, I; Kearney, T; Mohit, K; Meeran, K; Hill, N; Rees, A; Lansdown, A; Trainer, Peter J; Minder, Anna-Elisabeth H; Newell-Price, J

Affiliation

The Medical School, University of Sheffield, Sheffield.

Issue Date

2015-09-09

Metadata

Show full item record

Abstract

Cushing's syndrome is a severe condition with excess mortality and significant morbidity necessitating control of hypercortisolemia. There are few data documenting use of the steroidogenesis inhibitor metyrapone for this purpose.

Citation

Effectiveness of metyrapone in treating Cushing's Syndrome: a retrospective multicenter study in 195 patients. 2015: 20152616 J Clin Endocrinol Metab

Journal

The Journal of Clinical Endocrinology and Metabolism

URI

http://hdl.handle.net/10541/581084

DOI

10.1210/jc.2015-2616

PubMed ID

26353009

Type

Article

Language

ISSN

1945-7197

Collections

All Christie Publications